Singapore: Abbott revealed the results from two long-term, open-label studies, which evaluated the results of HUMIRA (ad...
Singapore: Experts from University of Edinburgh, UK, and Massachusetts-based biotechnology company Biogen Idec have join...
Singapore: Admedus, formerly Allied Healthcare, has signed a share purchase agreement to acquire an established manufact...
Singapore: Palatin Technologies collaboration with AstraZeneca is to be discontinued for the further development of AZD2...
Singapore: Results from a two-year study has demonstrated that Boehringer Ingelheim's Trajenta (linagliptin) provides si...
VM202 is a DNA-based drug that is designed to produce two isoforms of hepatocyte growth factor (HGF) - HGF 728 and HGF ...
Singapore: A report filed by Lux Research that tracks emerging technologies has said that China has invested a staggerin...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem received positive results from ...
Singapore: Australian Academy of Science and the Indonesian Academy of Sciences have signed a new memorandum of understa...
Singapore: Taiwan's PharmaEngine has signed research collaboration with Guangzhou BeBetter Medicine Technology to design...
Singapore: Amgen has terminated the partnership with AstraZeneca for co-development and commercialization of brodalumab,...
Singapore: Researchers at University of California, Los Angeles (UCLA), US, have reported the development of a molecular...
Singapore: Dainippon Sumitomo Pharma (DSP), headquartered in Japan, and Nippon Shinyaku, also a Japanese company, have c...
Singapore: US-based AVEO Oncology and Astellas Pharma have submitted a new drug application (NDA) to the US Food and Dru...
Singapore: Sanofi has submitted the marketing authorization application for Lyxumia, (lixisenatide), an investigational ...
Singapore: NovaSAID, part of Sweden-based Karolinska Development, and India- based Cadila Pharmaceuticals have entered i...
Singapore: Canadian scientists have revealed that the diabetes drug pioglitazone, also known as Actos, doubles the risk ...
Singapore: Taiwan's PharmaEngine has collaborated and signed research agreement with China's Guangzhou BeBetter Medicine...
